// App-Quantinova.ai

P500 : Post-marketing safety experience of vedolizumab in patients receiving concomitant treatment with other biologics

Researchers

Presenter

  • R D Cohen

Principal Investigators

  • F Bhayat

  • A Blake

  • S Travis

Medical Centers

  • University of Chicago Medicine, Department of Medicine, Inflammatory Bowel Disease Center, Chicago, USA

  • Takeda Pharmaceuticals International Co., Cambridge, MA

  • Oxford University Hospital, Translational Gastroenterology Unit, Oxford, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved